|
|
Volumn 94, Issue , 1998, Pages 89-106
|
|
Endocrine therapy of endometrial cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIESTROGEN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN;
ESTROGEN RECEPTOR;
GESTAGEN;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
DRUG EFFECT;
ENDOMETRIUM TUMOR;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
HYSTERECTOMY;
MENOPAUSE;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
PHYSIOLOGY;
REVIEW;
SURVIVAL RATE;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
ENDOMETRIAL NEOPLASMS;
ESTROGEN ANTAGONISTS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HUMANS;
HYSTERECTOMY;
MENOPAUSE;
MIDDLE AGED;
NEOPLASMS, HORMONE-DEPENDENT;
PROGESTINS;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
SURVIVAL RATE;
TAMOXIFEN;
|
|
EID: 0031629716
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-6189-7_6 Document Type: Review |
|
Times cited : (13)
|
|
References (84)
|
